Development partner to the global pharma industry

Lipidor is a Swedish, Stockholm based, company developing topical treatments and offering unique lipid based formulation opportunities for pharma companies. Present focus is on topical formulation candidates for psoriasis.

The fast track to innovative topical candidates

Lipidor develops improved versions of already marketed products in order to cover either unmet medical needs or improve the quality-of-life of the patient.

Pipeline

Current focus projects

Lipidor is targeting to move the candidates up to proof-of-concept and thereafter license the product and the technology to partners. Licensing discussions can start at any stage.

Completed

Ongoing

Project

Indication

Research

Pre-clinical

Phase I

Phase II

Phase III

AKP01
Calcipotriol
Indication
Psoriasis
Status
Research
Status
Pre-clinical
Status
Phase I
Status
Phase II
Status
Phase III
AKP02 generation 2
Calcipotriol
+ Betamethasone
Indication
Psoriasis
Status
Research
Status
Pre-clinical
Status
Phase I
Status
Phase II
Status
Phase III

About us

What makes Lipidor different?

The versatility of the AKVANO® delivery system has enabled the successful incorporation of more than hundred structurally different active pharmaceutical ingredients, used in different therapeutic applications.

Strong set of IPs

Lipidor holds a broad IPR position relating to AKVANO® in pharma, consumer health care and animal care. The patent strategy is designed to secure the most important markets in Europe, USA, Japan, Canada and China as well as several other territories.

Proven track record

Lipidor has extensive experience of managing successful clinical studies. Our experience range from from pre-clinical stages to successful phase III.

Long-term partner

Lipidor is a long-term partner with cutting-edge expertise and a strong commercial focus. To supplement our in-house competences we have formed partnerships with selected long-term collaborators within fields such as production, CRO, CMO and Commercialisation.

Collaboration

The Lipidor project set-up

Lipidor develops improved versions of already marketed products in order to cover either unmet medical needs or improve the quality-of-life of the patient. We’re a small, highly focused organisation working with selected partners in the various phases of a project development.

It all begins with AKVANO®

The versatility of AKVANO® delivery system has enabled the successful incorporation of more than hundred structurally very different active pharmaceutical ingredients, used in different therapeutic applications. The new projects to initiate are chosen based on a number of criteria, such as patients’ needs, the potential commercial value upon success as well as its potential for a successful regulatory approval.

Selected partners for clinical studies

To deliver fast and efficient clinical studies and arrive at proof-of-concept as efficiently as possible, Lipidor works with a number of selected partners to move each candidate forward. Our network consists of carefully selected professionals as well as companies such as CRO’s, CMO’s, manufacturing partners and suppliers of clinical testing material.

Regulatory approval and market registration

Lipidor is an innovative life-science company specialized in lipid-based formulations, managing and controlling every aspect of the development process. To register and launch pharmaceuticals on specific markets Lipidor outlicense formulations to pharma companies with the ability, reach and marketing experience needed.

Contact

Collaborations

We’re interested in getting in touch with potential commercial partners. Please don’t hesitate to reach out to us for any questions about our technology or about our way of working.

info@lipidor.se